Zobrazeno 1 - 10
of 27
pro vyhledávání: '"cGVHD"'
Autor:
Steven Z. Pavletic, Damir Nemet, Dina Ljubas Kelečić, Tamara Vukic, Dubravka Vitali Čepo, Ivan Sabol, Zeljko Krznaric, Nadira Duraković, Irena Karas, Ranka Serventi Seiwerth, Lana Desnica, Darija Vranešić Bender, Radovan Vrhovac, Drazen Pulanic, Zinaida Peric, Antonela Lelas
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose This study investigated the frequency and characteristics of sarcopenia among patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT) with a specific focus on the chronic graft-versus-host disease (cGVHD) population and
Autor:
Tobias Wertheimer, Tobias Bergler, Daniela Weber, Barbara Holler, Daniel Wolff, Wolfgang Herr, Klemens Angstwurm, Ernst Holler, Matthias Edinger, Matthias Fante
Publikováno v:
Annals of Hematology
We retrospectively analyzed the safety and efficacy of cyclophosphamide (cyclo) for salvage treatment of chronic graft-versus-host disease (cGvHD) and cGvHD-associated (glomerulo-)nephritis at our center between 01/2010 and 11/2019. We identified 13
Autor:
Daniel Wolff, Antonela Lelas, Hildegard Greinix, Drazen Pulanic, Steven Z. Pavletic, Günther Eissner
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Chronic graft-versus-host disease (cGvHD) is an immune mediated late complication of allogeneic hematopoietic stem cell transplantation (alloHSCT). Discovery of adequate biomarkers could identify high-risk patients and provide an effective pre-emptiv
Autor:
Risa Nomura, Ryuichi Nakagawa, Masatoshi Takagi, Tomohiro Morio, Keisuke Nakajima, Kei Takasawa, Kohsuke Imai, Kenichi Kashimada, Yuichi Miyakawa, Yuki Aoki, Mitsue Maru, Atsumi Tsuji-Hosokawa, Akito Sutani
Publikováno v:
Clinical Pediatric Endocrinology
In addition to malignant diseases, hematopoietic stem cell transplantation (HSCT) is also a vital option as a curative therapy for non-malignant diseases, such as immunodeficiency, and other hematological disorders. Not only for malignant diseases, b
Autor:
Hildegard Greinix, Nina Milutin Gašperov, Daniel Wolff, Magdalena Grce, Maja Pučić-Baković, Nuala Mooney, Dražen Pulanić, Ernst Holler, Daniela Weber, Katarzyna Bogunia-Kubik, Rachel E Crossland, Francesca Perutelli, Marit Inngjerdingen, Anne M. Dickinson
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2020, 11, ⟨10.3389/fimmu.2020.602547⟩
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology, Frontiers, 2020, 11, ⟨10.3389/fimmu.2020.602547⟩
Frontiers in Immunology, Vol 11 (2020)
Prognostic, diagnostic or predictive biomarkers are urgently needed for assessment of chronic graft-versus-host disease (cGvHD), a major risk for patients undergoing allogeneic hematopoietic stem cell transplantation. The main goal of this review gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c611cebbb3b17fd98d054e7dd0896c9
https://hal-cnrs.archives-ouvertes.fr/hal-03106409
https://hal-cnrs.archives-ouvertes.fr/hal-03106409
Autor:
Bruce R. Blazar, Gregory Miller, Wei Chen, Jing Liu, Melanie S. Nyuydzefe, Geoffrey R. Hill, Katharine M. Irvine, Michelle Melino, Wayne A. Schroder, Patrick Bertolino, Kelli P. A. MacDonald, Alexandra Zanin-Zhorov, Michele W.L. Teng, Christina Nalkurthi, Andrew D. Clouston
Publikováno v:
JHEP Reports
Background & Aims Fibrosis, the primary cause of morbidity in chronic liver disease, is induced by pro-inflammatory cytokines, immune cell infiltrates, and tissue resident cells that drive excessive myofibroblast activation, collagen production, and
Autor:
Mikael Sundin, Emma Watz, Ulla Axdorph Nygell, Gabriel Afram, Jonas Mattsson, Mats Remberger, Hans Hägglund, Michael Uhlin
Publikováno v:
Central European Journal of Immunology, Vol 44, Iss 1, Pp 84-91 (2019)
Central-European Journal of Immunology
Central-European Journal of Immunology
Introduction Different forms of graft-versus-host disease (GVHD) remain a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). The prognosis for steroid-refractory chronic GVHD (cGVHD) remains poor.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac97ef44a24aeed9cc9cf4bab05807dc
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-383038
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-383038
Autor:
Francesco Saraceni, Patrizia Bagnarelli, Paolo Barbatelli, Irene Federici, Giorgia Mancini, Ilaria Scortechini, Marianna Mariani, Attilio Olivieri, Mariana Gaetani, Maria Luisa Minnucci
Publikováno v:
Transplant Infectious Disease
Graft‐versus‐host disease (GVHD) is a common complication of hematopoietic stem cell transplant, which is known to be mediated by cytotoxic T‐cell effectors and dysregulated inflammatory cytokines. Similarly, the lung injury observed in severe
Autor:
Louise Bondeelle, Jean-David Bouaziz, Sylvie Chevret, Abdellatif Tazi, Gérard Socié, Laila Samy, Charlotte Hurabielle, Tiphaine Goletto, Flore Sicre de Fontbrune, Anne Bergeron, David Michonneau, Adrien Costantini
Publikováno v:
Biology of Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, Elsevier, 2020, 26, pp.2115-2120. ⟨10.1016/j.bbmt.2020.07.033⟩
Biology of Blood and Marrow Transplantation, 2020, 26, pp.2115-2120. ⟨10.1016/j.bbmt.2020.07.033⟩
Biology of Blood and Marrow Transplantation, Elsevier, 2020, 26, pp.2115-2120. ⟨10.1016/j.bbmt.2020.07.033⟩
Biology of Blood and Marrow Transplantation, 2020, 26, pp.2115-2120. ⟨10.1016/j.bbmt.2020.07.033⟩
International audience; Ruxolitinib, a selective Janus kinase (JAK)1/2 inhibitor, has recently been proposed for steroid-refractory chronic graft-versus host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation (HSCT), particularl
Publikováno v:
Cureus
Chronic graft-versus host disease (cGVHD) occurs in 30% to 70% of patients undergoing allogeneic hematopoietic cell transplantation (HCT). Cutaneous cGVHD affects 75% of cGVHD patients, causing discomfort, limiting the range of movement, and increasi